Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 2 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 58 Cisplatin 41 Capecitabine 27 Oxaliplatin 25 durvalumab 16 Fluorouracil 16 Leucovorin 15 S 1 (combination) 11 lenvatinib 10 Nivolumab 10 Irinotecan 10 pembrolizumab 8 apatinib 8 Immune Checkpoint Inhibitors 7 130-nm albumin-bound paclitaxel 7 tremelimumab 6 Bevacizumab 6 camrelizumab 5 Trastuzumab 5 Drug Therapy 5 Blood Specimen Collection 5 Albumin-Bound Paclitaxel 5 tislelizumab 4 irinotecan sucrosofate 4 Taxes 4 Liquid Biopsy 4 Folfox protocol 4 toripalimab 3 surufatinib 3 gemcitabine-oxaliplatin regimen 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Biliary Tract Neoplasms × DNA, Mitochondrial × Clear all

NCT06653127 2024-12-30

CCGLC-016

Tongji Hospital

Gastrointestinal

Biliary Tract Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡